Apathy in Parkinson's disease: Diagnostic and etiological dilemmas

Movement Disorders

Volumn 27, Issue 2, 2012, Pages 174-178

  Starkstein, Sergio E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apathy; Dementia; Depression; Dopamine; Parkinson's disease

Indexed keywords

ATOMOXETINE; LEVODOPA; METHYLPHENIDATE; RACLOPRIDE C 11; ROPINIROLE; TIANEPTINE;

APATHY; ARTICLE; BRAIN DEPTH STIMULATION; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; HUMAN; OCCUPATIONAL THERAPY; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; STRUCTURED INTERVIEW; SUBTHALAMIC DEEP BRAIN STIMULATION; VALIDATION PROCESS;

ANTIPARKINSON AGENTS; APATHY; DEEP BRAIN STIMULATION; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 84856950829     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.24061     Document Type: Article

References (40)

1. Starkstein S, Merello M, Jorge R, Brockman S, Bruce D, Power B. The syndromal validity and nosological position of apathy in Parkinson's disease. Mov Disord 2009; 15: 1211-1216.
2. Dujardin K, Sockeel P, Devos D, et al. Characteristics of apathy in Parkinson's disease. Mov Disord 2007; 22: 778-784.
3. Aarsland D, Larsen JP, Lim NG, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492-496.
4. Pluck GC, Brown RG. Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 636-642.
5. Pedersen KF, Alves G, Aarsland D, Larsen JP. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 2009; 80: 1279-1282.
6. Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci 1991; 3: 243-254.
7. Sims ACP. Symptoms in the mind: an introduction to psychopathology. Philadelphia: Elsevier Saunders; 2003.
8. Leentjens AF, Dujardin K, Marsh L, et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2008; 23: 2004-2014.
9. Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1992; 4: 134-139.
10. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 579-584.
11. Cummings JL. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997; 48( Suppl 6): S10-S16.
12. Fahn S, Elton E. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne CD, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan; 1987: 153-163.
13. Starkstein SE, Ingram L, Garau ML, Mizrahi R. On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry 2005; 76: 1070-1074.
14. Starkstein S, Leentjens AF. The nosological position of apathy in clinical practice. J Neurol Neurosurg Psychiatry 2008; 79: 1088-1092.
15. Robert P, Onyike CU, Leentjens AF, et al. Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 2009; 24: 98-104.
16. Drijgers RL, Dujardin K, Reijnders JS, Defebvre L, Leentjens AF. Validation of diagnostic criteria for apathy in Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 656-660.
17. Kirsch-Darrow L, Fernandez HF, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006; 67: 33-38.
18. Pedersen KF, Larsen JP, Alves G, Aarsland D. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 2009; 15: 295-299.
19. Temel Y, Kessels A, Tan S, Topdag A, Boon P, Visser-Vandewalle V. Behavioural changes after bilateral subthalamic stimulation in advanced Parkinson disease: a systematic review. Parkinsonism Relat Disord 2006; 12: 265-272.
20. Czernecki V, Pillon B, Houeto JL, et al. Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease? J Neurol Neurosurg Psychiatry 2005; 76: 775-779.
21. Czernecki V, Schupbach M, Yaici S, et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 2008; 23: 964-969.
22. Kirsch-Darrow L, Zahodne LB, Marsiske M, Okun MS, Foote KD, Bowers D. The trajectory of apathy after deep brain stimulation: from pre-surgery to 6 months post-surgery in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 182-188.
23. Le Jeune F, Drapier D, Bourguignon A, et al. Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology 2009; 73: 1746-1751.
24. Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010; 133: 1111-1127.
25. Drapier D, Drapier S, Sauleau P, et al. Does subthalamic nucleus stimulation induce apathy in Parkinson's disease? J Neurol 2006; 253: 1083-1091.
26. Castelli L, Lanotte M, Zibetti M, et al. Apathy and verbal fluency in STN-stimulated PD patients. An observational follow-up study. J Neurol 2007; 254: 1238-1243.
27. Denheyer M, Kiss ZH, Haffenden AM. Behavioral effects of subthalamic deep brain stimulation in Parkinson's disease. Neuropsychologia 2009; 47: 3203-3209.
28. Gervais-Bernard H, Xie-Brustolin J, Mertens P, et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J Neurol 2009; 256: 225-233.
29. Kirsch-Darrow L, Marsiske M, Okun M, Foote K, Bowers D. Longitudinal change in apathy following deep brain stimulation for Parkinson's Disease. Neurology 2009; 72: A221-A222.
30. Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, Dubois B. Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 2002; 40: 2257-2267.
31. Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Clin Ther 2009; 31: 89-98.
32. Reijnders JS, Scholtissen B, Weber WE, Aalten P, Verhey FR, Leentjens AF. Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 2010; 25: 2318-2325.
33. Levy R, Czernecki V. Apathy and the basal ganglia. J Neurol 2006; 253: 54-61.
34. Remy P, Doder M, Lees A, Turjanski N, Brooks D. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 2005; 128: 1314-1322.
35. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-928.
36. Laplane D, Dubois B. Auto-activation deficit: a basal ganglia related syndrome. Mov Disord 2001; 16: 810-814.
37. Brown RG, Pluck G. Negative symptoms: the 'pathology' of motivation and goal-directed behaviour. Trends Neurosci 2000; 23: 412-417.
38. Chatterjee A, Fahn S. Methylphenidate treats apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002; 14: 461-462.
39. Levin OS. Coaxil (tianeptine) in the treatment of depression in Parkinson's disease. Neurosci Behav Physiol 2007; 37: 419-424.
40. Weintraub D, Mavandadi S, Mamikonyan E, et al. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 2010; 75: 448-455.